Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bijl

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Lupus|December 13, 2006
Ultraviolet light and cutaneous lupusMarc Bijl, Cees G M Kallenberg
Molecular Medicine (Cambridge, Mass.)|February 18, 2014
Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosusFleur Schaper, Johanna Westra, Marc Bijl
Seminars in Immunopathology|December 6, 2015
Lupus erythematosus revisitedAnnegret Kuhn, Joerg Wenzel, Marc Bijl
Expert Review of Clinical Immunology|October 29, 2010
Treatment of lupus nephritisSebastian Dolff, Jo Hm Berden, Marc Bijl
Annals of the New York Academy of Sciences|August 30, 2005
Accelerated atherosclerosis in patients with systemic autoimmune diseasesKarina de Leeuw, Cees Kallenberg, Marc Bijl
Current Opinion in Rheumatology|December 20, 2012
Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal modelsFleur Schaper, Peter Heeringa, Marc Bijl, et al.
Nature Reviews. Rheumatology|December 10, 2014
Vaccination of patients with autoimmune inflammatory rheumatic diseasesJohanna Westra, Christien Rondaan, Sander van Assen, et al.
Kidney & Blood Pressure Research|May 24, 2007
Prognostic value of renal hemodynamic characteristics in patients with proliferative lupus nephritisHenk A Martens, Marc Bijl, Cees G M Kallenberg
Autoimmunity Reviews|April 7, 2007
Influenza vaccination in systemic lupus erythematosus: safe and protective?Bert Holvast, Anke Huckriede, Cees G M Kallenberg, et al.
Autoimmunity|May 23, 2007
Inflammatory clearance of apoptotic cells after UVB challengeMarc Bijl, Esther Reefman, Pieter C Limburg, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Lupus|December 13, 2006
Ultraviolet light and cutaneous lupusMarc Bijl, Cees G M Kallenberg
Molecular Medicine (Cambridge, Mass.)|February 18, 2014
Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosusFleur Schaper, Johanna Westra, Marc Bijl
Seminars in Immunopathology|December 6, 2015
Lupus erythematosus revisitedAnnegret Kuhn, Joerg Wenzel, Marc Bijl
Expert Review of Clinical Immunology|October 29, 2010
Treatment of lupus nephritisSebastian Dolff, Jo Hm Berden, Marc Bijl
Annals of the New York Academy of Sciences|August 30, 2005
Accelerated atherosclerosis in patients with systemic autoimmune diseasesKarina de Leeuw, Cees Kallenberg, Marc Bijl
Current Opinion in Rheumatology|December 20, 2012
Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal modelsFleur Schaper, Peter Heeringa, Marc Bijl, et al.
Nature Reviews. Rheumatology|December 10, 2014
Vaccination of patients with autoimmune inflammatory rheumatic diseasesJohanna Westra, Christien Rondaan, Sander van Assen, et al.
Kidney & Blood Pressure Research|May 24, 2007
Prognostic value of renal hemodynamic characteristics in patients with proliferative lupus nephritisHenk A Martens, Marc Bijl, Cees G M Kallenberg
Autoimmunity Reviews|April 7, 2007
Influenza vaccination in systemic lupus erythematosus: safe and protective?Bert Holvast, Anke Huckriede, Cees G M Kallenberg, et al.
Autoimmunity|May 23, 2007
Inflammatory clearance of apoptotic cells after UVB challengeMarc Bijl, Esther Reefman, Pieter C Limburg, et al.
Pageof 10